Testing for the classic hereditary breast cancer genes, BRCA1 and BRCA2, has been available and widely offered since their discovery in the 1990s. However, new technologies in genetic testing have recently uncovered information about other genes linked to hereditary breast cancer.
Hereditary Breast Ovarian Cancer Syndrome (BRCA1 / BRCA2)
Hereditary breast ovarian cancer syndrome is an abnormal version of the gene BRCA1 or BRCA2, which increases a person�s risk of developing various types of cancer
Adjuvant therapy is a term used to describe interventions given before or after tumor surgery to maximize the effectiveness of cancer treatment, which includes chemotherapy, radiation and the newer targeted and biological therapies.
We help to identify families that may have a hereditary breast and/or ovarian cancer syndrome and, when indicated, offer genetic testing, cancer screening and support.
Staffed by a team fully dedicated to breast imaging, Mass General Imaging offers access to breast imaging services at many community locations to provide you with the highest level of advanced quality care.
The Clinic for Reproductive Health and Cancer at Massachusetts General Hospital provides guidance on fertility preservation for cancer patients to help protect their future reproductive options.
News & Publications
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.